Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 47 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
461 18.2 months GBM (newly diagnosed) 4 Biologic therapy
Radiation
Duke University Medical Center United States 6/2005
Treatment Details: Patients: This Phase II trial involved 33 patients with malignant gliomas including: 27 with glioblastoma multiforme, 4 with anaplastic astrocytoma, and 2 with anaplastic oligodendroglioma.
 
462 18.2 months Metastatic, castration-resistant prostate cancer 4 Biologic therapy
San Camillo and Forlanini Hospitals Italy 2/2014
Treatment Details: Patients: This phase 3 study involved 199 metastatic castration-resistant prostate cancer patients who had received prior platinum-based chemotherapy. All patients were 75 years of age or
 
463 18.1 months Advanced NSCLC 4 Biologic therapy
Guangdong Lung Cancer Institute, Guangdong General Hospital China 9/2012
Treatment Details: Patients: This phase 3 study involved untreated advanced non-small cell lung cancer patients who were divided into two separate treatment groups. Of the total patient population, 78.5% wer
 
464 18.1 months Metastatic, castration-resistant prostate cancer 4 Biologic therapy
Chemotherapy
Hormone
Texas Oncology and US Oncology Research United States 11/2011
Treatment Details: Patients: This phase II study involved men with metastatic castration-resistant prostate cancer who were separated into two separate treatment groups. Group A had 110 patients with a media
 
465 18.1 months Malignant Pleural Mesothelioma 5 Radiation
Surgery
University of California, San Francisco United States 12/2002
Treatment Details: Patients: This study involved 28 patients with malignant pleural mesothelioma. (The number of patients started at 32, but several were excluded from the analysis because of various reasons.
 
466 18.1 months Metastatic colorectal cancer 5 Chemotherapy
Aichi Cancer Center Hospital Japan 9/2010
Treatment Details: Patients: This study involved patients with metastatic colorectal cancer. The patients were divided into 2 treatment groups. Group 1 included 213 patients with a median age of 63 years an
 
467 18.0 months Metastatic, castration-resistant prostate cancer 3 Biologic therapy
Chemotherapy
Memorial Sloan-Kettering Cancer Center United States 10/2009
Treatment Details: Patients: This study involved 36 men with metastatic castration-resistant prostate cancer. The median age was 66 years old, with a range of 52-84 years. Treatment: Patients were ad
 
468 18.0 months Metastatic colorectal cancer 4 Chemotherapy
Public Assistance Hospital of Paris, Paul Brousse Hospital France 7/2009
Treatment Details: Patients: This study involved 29 patients with metastatic colorectal cancer. They had all received prior treatment for their cancer. Their median age was 62.5, ranging from 35 to 75 years
 
469 18.0 months GBM 5 Chemotherapy
Columbia University Medical Center United States 3/2008
Treatment Details: Patients: This study involved 120 patients with recurrent high-grade gliomas. The types of gliomas were glioblastoma multiforme, anaplastic astrocytoma, or anaplastic oligodendroglioma. T
 
470 18.0 months Malignant Pleural Mesothelioma 3 Immunotherapy
Hopital de la Conception France 11/1998
Treatment Details: Patients: This Phase II study involved 22 patients with malignant pleural mesothelioma. Treatment: The treatment consisted of the intrapleural administration of interleukin-2. (Interleuk
 
Page 47 of 187  | Previous Page  | Next Page